Work

The value of TOP2A as a target for anthracycline-based chemotherapy in advanced endometrial carcinoma (EC): NRG Oncology/Gynecology Oncology Group study.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.e16509

Authors: Tatyana A. Grushko, Virginia L. Filiaci, Anthony G. Montag, Marsha A. Apushkin, Brandon Marzullo, Laura Monovich, Nilsa C. Ramirez, Michael J. Birrer, Olufunmilayo I. Olopade, Gini F. Fleming, NRG Oncology/Gynecologic Oncology Group

Institutions: University of Chicago Medical Center, Gynecologic Oncology Group, NRG Oncology, University at Buffalo, State University of New York, Nationwide Children's Hospital, Massachusetts General Hospital

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2597215670

Cites:

Cited by:

Related to: 10